VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,907,603 | -11.0% | 70,888 | -0.4% | 1.74% | -7.3% |
| Q2 2023 | $2,142,710 | -22.9% | 71,163 | -17.2% | 1.87% | -22.2% |
| Q1 2023 | $2,780,183 | +104496.8% | 85,941 | -7.3% | 2.41% | +2.2% |
| Q4 2022 | $2,658 | -99.9% | 92,749 | -0.1% | 2.36% | +19.4% |
| Q3 2022 | $2,239,000 | -7.5% | 92,823 | +5.0% | 1.97% | -2.6% |
| Q2 2022 | $2,421,000 | -28.1% | 88,435 | +0.7% | 2.03% | -20.0% |
| Q1 2022 | $3,367,000 | +10.1% | 87,801 | -8.0% | 2.53% | +11.8% |
| Q4 2021 | $3,058,000 | +2.2% | 95,486 | -6.0% | 2.27% | +0.8% |
| Q3 2021 | $2,993,000 | -12.8% | 101,555 | +0.5% | 2.25% | -10.1% |
| Q2 2021 | $3,432,000 | – | 101,003 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |